The discovery of a new use for a failed or existing drug has often been entirely serendipitous: a drug in development to treat angina failed, but became famous as Viagra when some of the test subjects reported interesting side effects. There are other notable examples, and now scientists are beginning to repurpose drugs in a more systematic way. How is drug repurposing research carried out, why is it important, and what are the hurdles to bringing these new uses to market? Hosted by Dr. Bruce Bloom.
Repurposing Drugs: Challenges and Triumphs from an Emerging Field

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
The discovery of a new use for a failed or existing drug has often been entirely serendipitous: a drug in development to treat angina failed, but became famous as Viagra when some of the test subjects reported interesting side effects. There are other notable examples, and now scientists are beginning to repurpose drugs in a more systematic way. How is drug repurposing research carried out, why is it important, and what are the hurdles to bringing these new uses to market? Hosted by Dr. Bruce Bloom.
Series Produced in Cooperation With
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Phase 3 study results of plozasiran in patients with FCS
IgG4-RD Case Conversations: Systemic Disease Infiltrating the Skull Base
IgG4-RD Case Conversations: The Peculiarities of Kidney Involvement
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis
Digesting IgG4-RD: An Interactive, Multidisciplinary Case Conference
Advancing TROP-2-Targeted ADCs in HR+ Breast Cancer: Navigating Today and Shaping Tomorrow
Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?